Paper14744487
Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier.
Godin B and 1 other. J Control Release, 2004. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. Papers, record 14744487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14744487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacitracin | Major topic |
| Cell Membrane | Major topic |
| Skin | Major topic |
| 3T3 Cells | |
| Animals | |
| Drug Carriers | |
| Drug Delivery Systems | |
| Humans | |
| Male | |
| Mice | |
| Permeability | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42488843 | Amentoflavone: A safe and novel penetration enhancer for transdermal applications. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42488843 | PubMed |
| 41552597 | (Ca/Zn)CO3 Microparticles Loaded with BacitracinAntibacterial and Osteogenic Dual Action Carriers. | ACS Omega | 2026 | https://conductscience.org/library/papers/41552597 | PubMed |
| 40917520 | Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40917520 | PubMed |
| 40835930 | Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40835930 | PubMed |
| 39789371 | Advancements in Transdermal Drug Delivery Systems: Harnessing the Potential of Macromolecular Assisted Permeation Enhancement and Novel Techniques. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/39789371 | PubMed |
| 36839978 | Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839978 | PubMed |
| 36499432 | Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499432 | PubMed |
| 35965326 | Functions and mechanisms of protein disulfide isomerase family in cancer emergence. | Cell Biosci | 2022 | https://conductscience.org/library/papers/35965326 | PubMed |
| 34959410 | Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34959410 | PubMed |
| 34940553 | Rutin-Loaded Nanovesicles for Improved Stability and Enhanced Topical Efficacy of Natural Compound. | J Funct Biomater | 2021 | https://conductscience.org/library/papers/34940553 | PubMed |
| 34884592 | Transmission Electron Microscopy as a Powerful Tool to Investigate the Interaction of Nanoparticles with Subcellular Structures. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884592 | PubMed |
| 34714214 | Nanoencapsulation of sulforaphane in broccoli membrane vesicles and their in vitro antiproliferative activity. | Pharm Biol | 2021 | https://conductscience.org/library/papers/34714214 | PubMed |
| 34685005 | Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34685005 | PubMed |
| 34631355 | Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: in vitro investigations and preclinical assessment. | 3 Biotech | 2021 | https://conductscience.org/library/papers/34631355 | PubMed |
| 34069489 | Formulative Study and Intracellular Fate Evaluation of Ethosomes and Transethosomes for Vitamin D3 Delivery. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34069489 | PubMed |
| 34065713 | EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment. | J Funct Biomater | 2021 | https://conductscience.org/library/papers/34065713 | PubMed |
| 34036520 | Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations. | Pharm Res | 2021 | https://conductscience.org/library/papers/34036520 | PubMed |
| 33742523 | Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. | Cancer Med | 2021 | https://conductscience.org/library/papers/33742523 | PubMed |
| 33072532 | Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement. | Adv Pharm Bull | 2020 | https://conductscience.org/library/papers/33072532 | PubMed |
| 32605117 | Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. | Molecules | 2020 | https://conductscience.org/library/papers/32605117 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14744487
GET https://conductscience.org/api/papers/v1/14744487/cited_by?page=2